• The Board

    Board 2015-2017


    • Chairperson

    • Gunter Sturm
    • Graz, Austria
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Secretary

    • Ewa Cichocka-Jarosz
    • Krakow, Poland
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    Members


    • Betul Ayse Sin
    • Ankara, Turkey
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Hanneke Oude Elberink
    • Groningen, Netherlands
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Ervin Mingomataj
    • Tirana, Albania
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Franziska RuĂ«ff
    • Germany
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Dario Antolin Amerigo
    • Madrid, Spain
    • This email address is being protected from spambots. You need JavaScript enabled to view it.


    • JM Representative

    • Elisa Boni
    • Como, Italy
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Webmaster

    • DarĂ­o AntolĂ­n-AmĂ©rigo
    • Madrid, Spain
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    Please address any comments and suggestions to the This email address is being protected from spambots. You need JavaScript enabled to view it..

    Last updated: 26 April 2016
  • About Us

    534From the EAACI Bylaws

    In order to allow EAACI to influence and keep updated information on matters related to allergy and clinical immunology, it has been decided to create “Interest Groups”. An Interest Group represents an area of general interest within allergology that is not well covered by any one of the EAACI Sections.


    Announcement:
    You may be interested in participating in our EAACI multicenter study EADOAS, that is about to start. EADOAS means “The effect of antihypertensive drugs on severity of anaphylaxis and side –effects during venom immunotherapy”. A sufficiently powered study on the effect of antihypertensive drugs is urgently needed. This will be the first well planned study on this topic. We plan to enroll 1319 patients, which is a lot, and we therefore would be happy, if you can join the study group. Please feel free to inform other interested centers. If you would like to join, you should be able to: - Include at least 30 patients. Most of them should get VIT, and 25-30% should take beta blockers and/or ACE inhibitors during VIT
    - To obtain approval of your local ethical review board
    - To create an informed consent form in your language based on the protocol and according to your local policies (German is available)
    - To perform standard diagnostic procedures to diagnose hymenoptera venom allergy and to perform VIT.
    - To store at least 2ml serum per patient at -20°C for further analysis (shipment costs will be covered)
    - To provide personal resources to enroll patients in the study and to complete paper and e-CRFs
    For further information, send an email to the leader of this interesting project Dr. Gunter Sturm: This email address is being protected from spambots. You need JavaScript enabled to view it.

    Announcement:
    The cross-cultural validation of the Vespid Quality of Life Questionnaire (VQLQ) is about to start.
    Would you like to collaborate in this interesting project? Send an email to (This email address is being protected from spambots. You need JavaScript enabled to view it.)
    Thank you very much
    Last updated: 25 November 2014
  • Introduction to Insect Venom Hypersensitivity IG

    534From the EAACI Bylaws

    In order to allow EAACI to influence and keep updated information on matters related to allergy and clinical immunology, it has been decided to create “Interest Groups”. An Interest Group represents an area of general interest within allergology that is not well covered by any one of the EAACI Sections.

     

     Announcement:

    The cross-cultural validation of the Vespid Quality of Life Questionnaire (VQLQ) is about to start.

    Would you like to collaborate in this interesting project? Send an email to (This email address is being protected from spambots. You need JavaScript enabled to view it.)

    Thank you very much

     

    Board 2015-2017

    Chairperson
                                         

     STU 5122            Gunter Sturm. Graz, Austria

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)

     

    Secretary


    Ewa Cichocka Jarosz     Ewa Cichocka-Jarosz. Krakow, Poland 

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)

     

    Members

    Betul Ayse Sin             Betul Ayse Sin. Ankara, Turkey

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)

     

     

     Hanneke Oude Elberink            Hanneke Oude Elberink. Groningen, Netherlands

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)

     

    Ervin Mingomataj            Ervin Mingomataj. Tirana, Albania

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)                          

         

    Rueff        Franziska Rueff. Germany

     (This email address is being protected from spambots. You need JavaScript enabled to view it.This email address is being protected from spambots. You need JavaScript enabled to view it.">)

                                         

                                   

     DarĂ­o AntolĂ­n            DarĂ­o AntolĂ­n-AmĂ©rigo. Madrid, Spain

    (This email address is being protected from spambots. You need JavaScript enabled to view it.)


    Junior Member Representative


    Elisa Boni2              Elisa Boni. MĂłdena. Italy

     

    Please address any comments and suggestions to the This email address is being protected from spambots. You need JavaScript enabled to view it..
    Last updated: 24 April 2016